相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The cytokine storm and COVID-19
Biying Hu et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review
Juan Pimentel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
Christopher M. Rubino et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2021)
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Anil Gupta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Nanomedicines accessible in the market for clinical interventions
Vedant Gadekar et al.
JOURNAL OF CONTROLLED RELEASE (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019
Jiong Yu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Molnupiravir in COVID-19: A systematic review of literature
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening
Toshiki Ebisudani et al.
CELL REPORTS (2021)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan et al.
LANCET RESPIRATORY MEDICINE (2021)
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin et al.
CELL (2021)
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology
Zhili Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
Shipo Wu et al.
LANCET INFECTIOUS DISEASES (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Animal models for SARS-CoV-2
Chung-Young Lee et al.
CURRENT OPINION IN VIROLOGY (2021)
A Quality by Design Framework for Capsule-Based Dry Powder Inhalers
Li Ding et al.
PHARMACEUTICS (2021)
Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206
Hadar Feinberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Inhaled Dry Powder Formulation of Tamibarotene, a Broad-Spectrum Antiviral against Respiratory Viruses Including SARS-CoV-2 and Influenza Virus
Qiuying Liao et al.
ADVANCED THERAPEUTICS (2021)
Nanotechnology-Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis
Zsuzsa Baranyai et al.
ADVANCED THERAPEUTICS (2021)
Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis
Hozaifa Khalil Elsawah et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Yuling Han et al.
NATURE (2021)
Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery
Qiaoyu Liu et al.
DRUG DISCOVERY TODAY (2020)
Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein
Wujun Dong et al.
ACTA PHARMACEUTICA SINICA B (2020)
Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for Pseudomonas aeruginosa Infections
Chiara Falciani et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
PLGA nanocapsules improve the delivery of clarithromycin to kill intracellular Staphylococcus aureus and Mycobacterium abscessus
Frantiescoli Anversa Dimer et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Delivery strategies for macromolecular drugs in cancer therapy
Qin Guo et al.
ACTA PHARMACEUTICA SINICA B (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Prediction of Aerosol Deposition in the Human Respiratory Tract via Computational Models: A Review with Recent Updates
Vu Khac Hoang Bui et al.
ATMOSPHERE (2020)
COVID-19: Abnormal liver function tests
Qingxian Cai et al.
JOURNAL OF HEPATOLOGY (2020)
An overview of the available treatments for chronic cavitary pulmonary aspergillosis
Inderpaul Singh Sehgal et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)
Effect of itraconazole on Staphylococcus aureus biofilm and extracellular vesicles formation
S. Frassinetti et al.
MICROBIAL PATHOGENESIS (2020)
Recent advances in the development of microparticles for pulmonary administration
Harsha Jain et al.
DRUG DISCOVERY TODAY (2020)
Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?
Lulu Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
Yong-Jian Geng et al.
CARDIOVASCULAR PATHOLOGY (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19
Priya Brunsdon et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta -analysis
Yong Hu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis
Ankur Sharma et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Central nervous system manifestations of COVID-19: A systematic review
Ali A. Asadi-Pooya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients (vol 182, pg 843, 2020)
Christoph Kreer et al.
CELL (2020)
Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases
Hana Douafer et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery
Andrew M. Shen et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Nebulized Lidocaine in COVID-19, An Hypothesis
Ziad A. Ali et al.
MEDICAL HYPOTHESES (2020)
Spontaneous community-acquired bacterial meningitis in adults admitted to the intensive care units in the Caribbean French West Indies: Unusual prevalence of Klebsiella pneumonia
Pascale Piednoir et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Pulmonary Delivery of Biological Drugs
Wanling Liang et al.
PHARMACEUTICS (2020)
Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
Xuanyou Jin et al.
ANTIBIOTICS-BASEL (2020)
Frequency of Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia spp. among patients with atypical pneumonia in Tehran
N. Noori Goodarzi et al.
NEW MICROBES AND NEW INFECTIONS (2020)
Repurposed Drugs Against COVID-19: Safety Concerns and Stockout
Jehan Zeb Khan et al.
HOSPITAL PHARMACY (2020)
Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need
Tulshidas S. Patil et al.
JOURNAL OF DRUG TARGETING (2019)
HDAC5 promotes Mycoplasma pneumoniae-induced inflammation in macrophages through NF-κB activation
Yuehua Zhao et al.
LIFE SCIENCES (2019)
Fluorescent reconstitution on deposition of PM2.5 in lung and extrapulmonary organs
Donghai Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Recent advances in aerosolised drug delivery
Akshay Chandel et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Kaksha Sankhe et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Youhan Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Confocal Laser Scanning Microscopy for Analysis of Pseudomonas aeruginosa Biofilm Architecture and Matrix Localization
Courtney Reichhardt et al.
FRONTIERS IN MICROBIOLOGY (2019)
NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization
Chao Song et al.
EXPERIMENTAL CELL RESEARCH (2019)
CD5L contributes to the pathogenesis of methicillin-resistant Staphylococcus aureus-induced pneumonia
Xun Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Pulmonary delivery of therapeutic proteins based on zwitterionic chitosan-based nanocarriers for treatment on bleomycin-induced pulmonary fibrosis
Guanglin Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Influence of stabilizer type and concentration on the lung deposition and retention of resveratrol nanosuspension-in-microparticles
Qiaoyu Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Stefano Aliberti et al.
JOURNAL OF INFECTION (2019)
Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29
Nicholas B. Carrigy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients
Takashi Iwanaga et al.
CLINICAL DRUG INVESTIGATION (2019)
Gene expression is influenced due to 'nano' and 'ionic' copper in pre-formed Pseudomonas aeruginosa biofilms
Nimisha Singh et al.
ENVIRONMENTAL RESEARCH (2019)
Mucus-penetrating polymeric nanoparticles for oral delivery of curcumin to inflamed colon tissue
Xin Zhou et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Recent progress in drug delivery
Chong Li et al.
ACTA PHARMACEUTICA SINICA B (2019)
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers
Lv Chen et al.
ADVANCED MATERIALS (2019)
Challenges and strategies in drug delivery systems for treatment of pulmonary infections
Duy-Khiet Ho et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults
Tobias Welte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Revisiting the Cardiotoxic Effect of Chloroquine
Marguerite Blignaut et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
Treatment of Drug - Susceptible Tuberculosis
Beth Shoshana Zha et al.
CLINICS IN CHEST MEDICINE (2019)
Capturing the Onset of Bacterial Pulmonary Infection in Acini-On-Chips
Arbel Artzy-Schnirman et al.
ADVANCED BIOSYSTEMS (2019)
Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases
Stephen P. Newman
ADVANCED DRUG DELIVERY REVIEWS (2018)
Chemical modification of drug molecules as strategy to reduce interactions with mucus
Francisca Araujo et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles
Maria Garcia-Diaz et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Repurposing of gamma interferon via inhalation delivery
Gerald C. Smaldone
ADVANCED DRUG DELIVERY REVIEWS (2018)
PEGylation for enhancing nanoparticle diffusion in mucus
Justin T. Huckaby et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy
Melissa Quinn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies
Nashwa Osman et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?
Elsa Bodier-Montagutelli et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Macrophages: Their role, activation and polarization in pulmonary diseases
Shweta Arora et al.
IMMUNOBIOLOGY (2018)
Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A State-of-the-Art Review
Tulshidas S. Patil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin
Laura Mueller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection
Ching-Yee Loo et al.
PHARMACEUTICAL RESEARCH (2018)
Evolution of high-level resistance during low-level antibiotic exposure
Erik Wistrand-Yuen et al.
NATURE COMMUNICATIONS (2018)
Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Jimin Zhang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections
Rachit Agarwal et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery
Andrew R. Martin et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Is there room for further innovation in inhaled therapy for airways disease?
Martyn F. Biddiscombe et al.
BREATHE (2018)
Looking ahead: where to next for animal models of bronchopulmonary dysplasia?
Claudio Nardiello et al.
CELL AND TISSUE RESEARCH (2017)
Dry powder inhalation: past, present and future
A. H. de Boer et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Computational analysis of aerosol-dynamics in a human whole-lung airway model
Arun V. Kolanjiyil et al.
JOURNAL OF AEROSOL SCIENCE (2017)
Aerosol dynamics model for the simulation of hygroscopic growth and deposition of inhaled NaCl particles in the human respiratory tract
Renate Winkler-Heil et al.
JOURNAL OF AEROSOL SCIENCE (2017)
Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy
Pengfei Zhao et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Effects of fluorosurfactant structure and concentration on drug availability and biocompatibility in water-in-perfluorocarbon emulsions for pulmonary drug delivery
Ryan A. Orizondo et al.
COLLOID AND POLYMER SCIENCE (2017)
Drug delivery to the lungs: challenges and opportunities
Stephen P. Newman
THERAPEUTIC DELIVERY (2017)
Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis
Anuradha Gupta et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Modeling particle deposition in the Balb/c mouse respiratory tract
Renate Winkler-Heil et al.
INHALATION TOXICOLOGY (2016)
Particle deposition in a realistic geometry of the human conducting, airways: Effects of inlet velocity profile, inhalation flowrate and electrostatic charge
P. G. Koullapis et al.
JOURNAL OF BIOMECHANICS (2016)
Pulmonary delivery of cationic gold nanoparticles boost antigen-specific CD4+ T Cell Proliferation
Emilie Seydoux et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Long Term Culture of the A549 Cancer Cell Line Promotes Multilamellar Body Formation and Differentiation towards an Alveolar Type II Pneumocyte Phenotype
James Ross Cooper et al.
PLOS ONE (2016)
DRUG DEVELOPMENT Beleaguered phage therapy trial presses on
Kelly Servick
SCIENCE (2016)
Intramacrophage Survival for Extracellular Bacterial Pathogens: Mgtc As a Key Adaptive Factor
Claudine Belon et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films
Elisa Parra et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2015)
Recent advances in controlled pulmonary drug delivery
Zhenglin Hang et al.
DRUG DISCOVERY TODAY (2015)
Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome
Brijeshkumar Patel et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Pulmonary drug delivery systems for tuberculosis treatment
Dinh-Duy Pham et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Dual pancreas- and lung-targeting therapy for local and systemic complications of acute pancreatitis mediated by a phenolic propanediamine moiety
Jianbo Li et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Model of mucociliary clearance in cystic fibrosis lungs
P. Kurbatova et al.
JOURNAL OF THEORETICAL BIOLOGY (2015)
Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections
Sarah C. Mansour et al.
JOURNAL OF PEPTIDE SCIENCE (2015)
Mechanisms of Pharmaceutical Aerosol Deposition in the Respiratory Tract
Yung Sung Cheng
AAPS PHARMSCITECH (2014)
Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies
Ivana d'Angelo et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Emerging aerosol drug delivery strategies: From bench to clinic
Bruce K. Rubin et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Delivery strategies for sustained drug release in the lungs
Cristina Loira-Pastoriza et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Combination of doxorubicin-based chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles
Xiaozheng Shi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Medical nanoparticles for next generation drug delivery to the lungs
Sabine H. van Rijt et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells
Anna C. Zemke et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
A Pharmacokinetics and Safety Comparison of a Highly Concentrated Tobramycin Solution with TOBI
Matthias Griese et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
Jung Soo Suk et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A novel in vitro co-culture system allows the concurrent analysis of mature biofilm and planktonic bacteria with human lung epithelia
Laura L. Bowler et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2014)
Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation
David Cipolla et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
Anna M. Mielech et al.
VIROLOGY (2014)
Molecular mechanisms that influence the macrophage M1-M2 polarization balance
Nan Wang et al.
FRONTIERS IN IMMUNOLOGY (2014)
Nanoparticle diffusion in respiratory mucus from humans without lung disease
Benjamin S. Schuster et al.
BIOMATERIALS (2013)
Targeted drug delivery to macrophages
Narendra K. Jain et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Antibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible for community-acquired pneumonia in children
Miyuki Morozumi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges
Christian A. Ruge et al.
LANCET RESPIRATORY MEDICINE (2013)
Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Laura M. Ensign et al.
ADVANCED MATERIALS (2012)
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Moritz Beck-Broichsitter et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers
Francesca Ungaro et al.
JOURNAL OF CONTROLLED RELEASE (2012)
A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia
Brian Button et al.
SCIENCE (2012)
Models and approaches for anti-TB drug testing
Yuliya Yasinskaya et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Influence of particle size on regional lung deposition - What evidence is there?
Thiago C. Carvalho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
David E. Geller et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2011)
Aerosol drug delivery: developments in device design and clinical use
Myrna B. Dolovich et al.
LANCET (2011)
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine
Jung Soo Suk et al.
NANOMEDICINE (2011)
Micro- and nanocarrier-mediated lung targeting
Balak D. Kurmi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
The resolution of inflammation: Anti-inflammatory roles for NF-κB
Toby Lawrence et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) Self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres
Ibrahim M. E-Sherbiny et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Advances in inhalation therapy in pediatrics
Fabio Pereira Muchao et al.
JORNAL DE PEDIATRIA (2010)
Update on Macrophage Clearance of Inhaled Micro- and Nanoparticles
Marianne Geiser
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2010)
A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery
Oshrat Harush-Frenkel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery
Catherine M. Greene et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
A. Wright et al.
CLINICAL OTOLARYNGOLOGY (2009)
Comparison of analytical and CFD models with regard to micron particle deposition in a human 16-generation tracheobronchial airway model
Zhe Zhang et al.
JOURNAL OF AEROSOL SCIENCE (2009)
Simultaneously Manufactured Nano-In-Micro (SIMANIM) Particles for Dry-Powder Modified-Release Delivery of Antibodies
Richard S. Kaye et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
The ΔF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability
Sophie Moreau-Marquis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Structure and function of the polymeric mucins in airways mucus
David J. Thornton et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Current Concepts: Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sanjay Sethi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The impact of vaccines on pneumonia:: Key lessons from Haemophilus influenzae type b conjugate vaccines
Bradford D. Gessner et al.
VACCINE (2008)
Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway
Manoj K. Pandey et al.
BLOOD (2007)
The nanoscale in pulmonary delivery. Part 2: formulation platforms
Philippe G. A. Rogueda et al.
EXPERT OPINION ON DRUG DELIVERY (2007)
NanoCipro encapsulation in monodisperse large porous PLGA microparticles
Matthew M. Arnold et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Prediction of particle deposition in the human lung using realistic models of lung ventilation
B. Asgharian et al.
JOURNAL OF AEROSOL SCIENCE (2006)
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations
Alberto Papi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Biofilms: the matrix revisited
SS Branda et al.
TRENDS IN MICROBIOLOGY (2005)
Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres
K Makino et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2003)
Zanamivir - An update of its use in influenza
SM Cheer et al.
DRUGS (2002)
Phages and their application against drug-resistant bacteria
N Chanishvili et al.
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2001)
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance
C Bosquillon et al.
JOURNAL OF CONTROLLED RELEASE (2001)
分享论文
